HSBC Holdings’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-189,723
| Closed | -$12.9M | – | 2795 |
|
2022
Q3 | $12.9M | Buy |
+189,723
| New | +$12.9M | 0.02% | 642 |
|
2022
Q2 | – | Sell |
-35,431
| Closed | -$1.23M | – | 3044 |
|
2022
Q1 | $1.23M | Sell |
35,431
-71,635
| -67% | -$2.48M | ﹤0.01% | 1526 |
|
2021
Q4 | $3.14M | Buy |
107,066
+5,593
| +6% | +$164K | ﹤0.01% | 1166 |
|
2021
Q3 | $2.61M | Buy |
101,473
+34,410
| +51% | +$884K | ﹤0.01% | 1121 |
|
2021
Q2 | $2.35M | Buy |
67,063
+26,543
| +66% | +$932K | ﹤0.01% | 1094 |
|
2021
Q1 | $1.66M | Sell |
40,520
-5,981
| -13% | -$245K | ﹤0.01% | 1105 |
|
2020
Q4 | $2.01M | Buy |
46,501
+35,045
| +306% | +$1.52M | ﹤0.01% | 1027 |
|
2020
Q3 | $632K | Buy |
11,456
+4,422
| +63% | +$244K | ﹤0.01% | 1413 |
|
2020
Q2 | $444K | Sell |
7,034
-52,789
| -88% | -$3.33M | ﹤0.01% | 1567 |
|
2020
Q1 | $3.01M | Buy |
59,823
+53,857
| +903% | +$2.71M | 0.01% | 793 |
|
2019
Q4 | $476K | Buy |
5,966
+89
| +2% | +$7.1K | ﹤0.01% | 1733 |
|
2019
Q3 | $285K | Buy |
+5,877
| New | +$285K | ﹤0.01% | 2072 |
|